Uric acid: a novel mediator and marker of risk in chronic kidney disease? - Wikidata - awgldk - TriplyDB

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

http://www.wikidata.org/entity/Q33913892

about

The association between risk of airflow limitation and serum uric acid measured at medical health check-ups Uric acid: the past decade Association of a polymorphism in a gene encoding a urate transporter with CKD progression.Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population.Risk factors for progression of chronic kidney disease.Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors"Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.Correlation between renal function and common risk factors for chronic kidney disease in a healthy middle-aged population: a prospective observational 2-year study.Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort.Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout New and improved strategies for the treatment of gout Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study.The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study.Epidemiology of chronic kidney disease in children.The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease Uricases as therapeutic agents to treat refractory gout: Current states and future directions.Efficacy and safety of febuxostat in patients with hyperuricemia and gout.Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis.Longitudinal Study of Serum Uric Acid, Nutritional Status, and Mortality in Maintenance Hemodialysis Patients Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006.Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy.Urine NGAL and KIM-1 in children and adolescents with hyperuricemia Secreted klotho and chronic kidney disease Genome-wide association analysis confirms and extends the association of SLC2A9 with serum uric acid levels to Mexican Americans Uric acid level and erectile dysfunction in patients with coronary artery disease.The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease.Is there anything good in uric acid?Hyperuricemia and gout: new concepts in diagnosis and management.Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.Uric acid and the kidney.Febuxostat: drug review and update.Relationship between uric acid levels and risk of chronic kidney disease in a retrospective cohort of Brazilian workers Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice.Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients.Urate-Lowering Therapy Ameliorates Kidney Function in Type 2 Diabetes Patients With Hyperuricemia.Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study.Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease.

P2860

Q33596469-0B814C90-6E05-4FBA-AE57-B04EE041C6A5 Q33690653-CB33E036-DEE3-4782-87D9-FD427FF5EE02 Q33715840-5294C07E-55CD-4309-8D03-520CF8F1C9D7 Q33770852-211925B8-2291-4AF5-8562-1F9C589F5FF6 Q33905585-04328F28-CABC-4FB9-AC22-EA1D59C454B6 Q34169794-68DAE34A-E1AC-45E1-B578-17E0E70CEF42 Q34367656-23CDC1C0-E9C2-426C-93A4-C00E92378993 Q34455166-622E0305-54B4-4E36-9F57-545C59D4C171 Q34514455-990CD426-81DA-40F2-AB87-D756CB50FE37 Q34556186-E8C1A2C8-22A4-4BF3-A831-9816E4CB3E72 Q34590007-37DB74F5-87A0-49CC-88E2-E596E7DD5CC1 Q34737229-4A74C7EE-AF44-4595-9194-2979E7E7A304 Q35026692-4B0D1E71-2FF1-4A47-9E14-6B8EE811C4E7 Q35134716-825DBC0A-750F-4A94-BBDF-8A987E994F25 Q35167380-A2C01A58-7D2D-44CE-AB39-11635E602658 Q35691019-877745A7-FA22-45F8-A389-022476FCA593 Q35914820-AE405F4D-5A0E-404E-9F77-50FC3621C0BF Q36002499-A4ABB54D-462F-4B21-8683-B141B4348408 Q36059557-1B81345F-5C9C-4EB1-AB7F-930A1201AF30 Q36251821-A067BE2F-87C1-4CB0-9F7B-C1E9D97A4FB6 Q36965118-C72D6A5F-25A6-4221-826A-5DE97BCAE0C0 Q36979391-30C42C0F-FD2A-45FF-B2E4-1F7DF996EBA2 Q36982068-8C54B731-D408-44B7-83F6-8247A2663463 Q37043276-F73D108E-01D6-4CB1-B0A7-4F6501F519C4 Q37190542-7C8A2FA0-87D9-42E9-A3E6-CB6A5225F3E9 Q37394322-7A34B062-2750-4DEF-8FEE-8DF6BE23E345 Q37655080-32F09F03-B650-4EFB-AFEE-F8789C07EDDA Q37902094-79F0B8F9-079E-4475-B670-2B17F49B95D5 Q37930298-EE010D24-C942-465D-B569-3CF241C32CAD Q38074338-C50CDCA0-9702-4344-9E47-230E7C6DA789 Q38107939-DDF46586-2761-48A0-A572-BF0B9141D6D9 Q38119133-82D9DB36-577F-4BA9-85FE-85FC7E20CB12 Q38200657-6048DCAD-0892-4632-A83A-1FC65D8DDA4E Q38632200-6D247B67-25C0-42AF-9A5F-B61FE1D11805 Q38818748-4B9B1690-20D3-4185-8EB6-328971B34E9A Q38892582-E4075982-29FF-4E02-9BA2-851BB7BC28CA Q42136564-A8313324-E3F2-4E28-B6FA-A9E2218D8BF8 Q45158703-A9533E24-316B-4EE7-9FC3-DFC2BF9B6B3D Q47158335-4F5039EE-D598-4A89-9D8C-1DC7E9C60B1B Q47808087-FFED2748-8E75-49F0-83D2-5AD66D155B39

P2860

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

http://www.wikidata.org/entity/Q33913892

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

@ast

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

@en

type

label

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

@ast

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

@en

prefLabel

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

@ast

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

@en

P1433

Q33913892-98FD11F7-FB7D-40E0-89E4-A82A1AAF0CF5

P1476

Q33913892-6322A599-AD51-4F34-B51B-3239B9924228

P2093

Q33913892-47E81703-9926-45AC-9908-DF750FFA67F8

P2860

Q33913892-030904CF-0543-4C28-AC2D-FF98BC12489C

Q33913892-137694FF-D7F9-4FD2-ACE9-6D25E83C6FF6

Q33913892-212788A4-EF30-4921-9631-E26B367EACAE

Q33913892-218F8C09-A92E-4750-9DE4-7E97C6FFF28B

Q33913892-3853A0E4-EDF4-4C04-9FAD-E8CA8B939573

Q33913892-3A832076-E60F-458A-B3ED-AEF6164E91F1

Q33913892-415C96BB-2927-4234-9B73-DCE858B873CF

Q33913892-46FBD4AE-6570-4514-B4DE-DD589764631A

Q33913892-652C55DD-5D78-4E32-9296-AABA0B2F0641

Q33913892-755548B7-29E0-42BE-9B3F-99CFAF49DA17

P304

Q33913892-E3B48BDE-371C-46B5-8855-7E7AA4D81E20

P31

Q33913892-0DA81EA3-DEB6-4AC1-B5FE-65DBB4F494B8

P356

Q33913892-37FD9360-A57E-41BC-9BBE-5E58C8D05103

P433

Q33913892-DD7532B9-0D03-4A50-86FD-A05CA1478E88

P478

Q33913892-2653E753-2C70-4688-9273-904EFF4C072B

P50

Q33913892-619AFCDB-EC06-4DF2-9F27-1B74ED414F1D

P577

Q33913892-A2203B00-825D-4214-B81C-7DD9A45166E4

P698

Q33913892-B6C321E8-E403-4231-B13E-EC2129D5BCDC

P932

Q33913892-1A237D94-5B67-41F1-9816-C69423B613D8

P356

MNH.0B013E328330D9D0

P1433

Current Opinion in Nephrology and Hypertension

P1476

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

@en

P2093

Daniel I Feig

http://www.w3.org/2001/XMLSchema#string

P2860

Uric acid elimination in the urine. Pathophysiological implications

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

Hyperuricemia in childhood primary hypertension.

Uric acid and incident kidney disease in the community.

Elevated uric acid increases the risk for kidney disease.

Pathogenesis of essential hypertension: historical paradigms and modern insights.

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Uric acid and long-term outcomes in CKD

Community-based study on CKD subjects and the associated risk factors.

P304

526-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MNH.0B013E328330D9D0

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19654543

http://www.w3.org/2001/XMLSchema#string

P932

2885828

http://www.w3.org/2001/XMLSchema#string